Suresh S. Ramalingam, MD, FASCO Profile
Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

5,655
Followers
980
Following
156
Media
1,417
Statuses

Executive Director @WinshipAtEmory | Professor @EmoryUniversity |Associate VP for Cancer, Woodruff Health Sciences Center I Opinions are my own.

Atlanta, GA
Joined July 2009
Don't wanna be here? Send us removal request.
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
2 years
Celebrating the new paper in ⁦ @CellCellPress ⁩ with a cake… literally! ⁦ @WinshipAtEmory ⁩ ⁦ @HaianFu ⁩ ⁦ @weibzhou ⁩ ⁦ @EmoryUniversity ⁩.
Tweet media one
24
44
1K
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
3 years
I am incredibly honored and excited to be appointed as the Executive Director of @WinshipAtEmory . Very thankful to my family, friends, mentors and colleagues who have provided guidance & support over the years.
@WinshipAtEmory
Winship Cancer Institute of Emory University
3 years
Internationally renowned thoracic oncologist and physician scientist, Suresh S. Ramalingam, MD, has been named Winship's executive director. He begins his new post July 1. Congratulations @RamalingamMD , we're thrilled to have you at the helm! ➡️
Tweet media one
22
18
160
70
27
360
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
5 years
Happy to share the FLAURA study OS results; just published in @NEJM @WinshipAtEmory @EmoryMedicine @emoryhealthcare #LCSM .
Tweet media one
12
84
286
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
5 years
Osimertinib is the first TKI to improve OS over another TKI across the entire Oncology landscape! #ESMO19 @AstraZeneca @WinshipAtEmory #LCSM . Honored to lead this study and present the data!
Tweet media one
20
66
271
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
4 years
I am honored and excited! Thanks to @DrFadloKhuri for his outstanding leadership of the journal for the past 10 years. @JournalCancer @WinshipAtEmory @ACSNews @EmoryMedicine
@JournalCancer
ACS Journal Cancer
4 years
📢We are very pleased to announce Suresh S. Ramalingam, MD ( @RamalingamMD ) as our new Editor-in-Chief beginning July 2021. Dr. Ramalingam is currently Deputy Director @WinshipAtEmory and Chest & Lung Disease Section Editor of Cancer. Please join us in welcoming Dr. Ramalingam!👏
6
25
141
39
19
238
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
3 years
With FDA approval of #sotorasib there are 9 targets with proven therapies in #NSCLC . Let us make sure that every patient gets NGS testing at diagnosis. @WinshipAtEmory @IASLC #LCSM @ASCO
5
48
224
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
2 years
Excited to welcome ⁦ @reshmajagsi ⁩ on her first day at ⁦ @WinshipAtEmory ⁩ ⁦ @EmoryMedicine ⁩ as chair of Rad Onc.⁦ @EmoryUniversity ⁩ ⁦ @emoryhealthcare ⁩ ⁦ @NRGonc
Tweet media one
4
11
171
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
5 years
Can we ask the insurance companies to place a temporary freeze on peer-to-peer requests during this crisis? I did three of them this week! @ASCO @mtmdphd @VincentRK @drdonsdizon @montypal @drgandara @HwakeleeMD @LeciaSequist @HosseinBorghaei @IASLC @teekayowo @wallyjc
11
34
159
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
2 years
Excited to welcome @reshmajagsi as the next chair of Radiation Oncology at @EmoryMedicine @WinshipAtEmory . @ASCO @NRGonc @SWOG @theNCI .
@WinshipAtEmory
Winship Cancer Institute of Emory University
2 years
Internationally recognized breast cancer and bioethics researcher and radiation oncologist, Reshma Jagsi, MD, DPhil, will join @EmoryMedicine and Winship as chair of the Department of Radiation Oncology, effective Nov. 7, 2022. #RadOnc ➡️
Tweet media one
50
44
496
9
10
158
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
5 years
Thanks to @ASCO for this wonderful recognition. #ASC019 @WinshipAtEmory
@WinshipAtEmory
Winship Cancer Institute of Emory University
5 years
Congratulations ⁦ @RamalingamMD ⁩ for being honored as a FASCO, Fellow of the American Society of Clinical Oncology, #ASCO19 for you commitment, dedication and service.
Tweet media one
Tweet media two
2
7
47
23
12
154
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
4 years
From my photo archives- will cherish this one as we mourn the loss of Rep. John Lewis, a hero by every definition of the word. The nation has lost one of its great sons.
Tweet media one
1
10
142
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
5 years
Another exciting presentation on immunotherapy at #ESMO2019 and a NEJM paper to go with it. #LCSM . more good news for patients. @WinshipAtEmory @EmoryMedicine @bmsnews
Tweet media one
4
42
128
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
4 years
I voted in-person today, the first day of early voting in Georgia for racial justice, a science- driven society and restoration of decency. Thanks to @emoryhealthcare for providing time off to #vote .
0
6
127
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
6 years
CT screening reduces lung cancer mortality by 39% in women and 24% in men. Let us ensure that every at risk individual is screened. @IASLC #wclc2018 @WinshipAtEmory #LCSM
3
63
123
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
5 months
Great to have @LealTiciana lead @WinshipAtEmory lung program to the next level! Congrats!
@WinshipAtEmory
Winship Cancer Institute of Emory University
5 months
Congrats to Ticiana Leal, MD, who has been named the new leader of the Lung Cancer Disease Team at Winship, effective immediately. Dr. Leal will lead the multidisciplinary disease team in advancing clinical, translational and catchment-area priorities for lung cancer.
Tweet media one
1
2
38
18
9
122
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
4 years
Even as we celebrate research success at #ASCO20 , it is hard not to shed tears for the injustice that happen(s)ed around us this week. I take the knee locking hands with ⁦ @Kaepernick7 ⁩ today. What about you?
6
13
113
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
4 years
Congrats to my friend and colleague @HwakeleeMD for her appointment as the Deputy Director of @StanfordCancer and Director of Medical Oncology. @Stanford . Well done! @WinshipAtEmory @IASLC #LCSM
13
2
114
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
3 years
It has been an incredible honor to serve as the @eaonc Thoracic Committee chair for the past 10 years. Delighted to pass the torch to @JulieBrahmer and @HosseinBorghaei . Please join me in congratulating them. @HwakeleeMD @WinshipAtEmory @EmoryMedicine
8
10
108
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
5 years
Wonderful to run into ⁦ @DrSanjayPopat ⁩ at the #ICC Cricket World Cup at the London Oval. Team India had a magnificent innings with the bat. Thinking of our Aussie friends Ben Solomon, Mike Boyer. ⁦ @WinshipAtEmory
Tweet media one
11
3
107
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
1 year
Very proud of my @WinshipAtEmory colleagues whose dedication and commitment brings us closer to achieving our mission of discovering cures for cancer and inspiring hope with every passing day! @theNCI @WinshipAtEmory
@WinshipAtEmory
Winship Cancer Institute of Emory University
1 year
We're proud to have received renewal of the prestigious #ComprehensiveCancerCenter designation from @theNCI , ensuring our continuing place in the top tier of U.S. cancer centers. Learn what it means for patients with cancer in GA: .
2
5
46
6
8
98
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
1 year
Our amazing new ⁦ @WinshipAtEmory ⁩ Midtown set to inaugurate today! Research- driven multidisciplinary patient-centered cancer care- ‘The Winship Way’! Thanks to so many who have made this a reality. ⁦ @EmoryUniversity ⁩ ⁦ @emoryhealthcare
Tweet media one
6
13
91
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
1 year
Great to be at the Capitol Hill with ⁦ @KFKerstannPhD ⁩ to advocate for cancer research funding. #AACIOnTheHill #AACROnTheHill #FundNIH #FundNCI @WinshipAtEmory
Tweet media one
3
9
92
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
5 months
Grateful for the support from @ConquerCancerFd in 2006 CDA, a game changer for my career development. That award was to conduct research on targeted therapies for lung cancer. @ASCO @WinshipAtEmory
@ConquerCancerFd
Conquer Cancer, the ASCO Foundation
5 months
We are proud to share that @RamalingamMD , a 2006 Conquer Cancer Career Development Award recipient, was met with a standing ovation from the #ASCO24 plenary session crowd as he presented breakthrough results from the phase 3 LAURA study. Learn more @ASCO
2
12
62
2
13
92
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
1 year
A tremendous honor to meet Her Royal Highness Princess Dina Mired of Jordan ⁦ @dinamired ⁩ at #WCLC2023 @IASLC ⁩. Her speech calling for equity in cancer care is a call to action for all of us. ⁦ @WinshipAtEmory
Tweet media one
0
3
88
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
4 years
Congrats to recipients of @IASLC Distinguished Awards. L These leaders have inspired progress in lung cancer through decades of excellence. #LCSM #WCLC20 @HwakeleeMD
Tweet media one
2
14
88
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
7 years
Excited to learn about FDA approval of osimertinib for 1st line treatment of EGFR MT NSCLC today. @WinshipAtEmory #LCSM @EGFRResisters
2
26
86
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
4 years
Checkmate 743 demonstrates superiority for Ipi plus nivo over chemo in mesothelioma. Hazard ratio 0.75. @IASLC #VPS20 . A new front line option for meso.
1
19
83
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
4 years
5
0
79
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
6 years
I voted this am; to change the political discourse, for a science-driven society, for fairness and justice, for improved gun safety, quality education for all and healthcare for all! Did you vote?
4
8
81
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
1 year
Remarkable results from MARS2 study for mesothelioma. No role for surgery in early stage disease. Congrats to the study team from @UK . ⁦ @IASLC #wclc23 @WinshipAtEmory
Tweet media one
4
24
82
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
5 years
Lung cancer mortality reducing rapidly in the United States: if only we can increase adoption of CT screening, we can do even better! #LCSM @winshipatEmory Cancer statistics, 2020
1
33
82
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
4 years
#RBG ’s death is an immeasurable loss to our country. I can’t stop thinking of the cascade of events that will unfold in the upcoming weeks, none of which are likely good for the future. #vote
1
3
79
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
2 years
Winston Churchill was opposed to granting independence to India as he believed ‘the Indians cannot be trusted to rule themselves’! How quickly the wheels of history have turned! Happy Diwali! ⁦ @cspramesh
7
10
77
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
3 years
Immense thanks and gratitude to @DrFadloKhuri for his leadership of @JournalCancer for the past 10 years. I am honored and excited to succeed him. He has positioned us extremely well to move the journal to greater heights. @AUB_Lebanon @WinshipAtEmory @EmoryMedicine
@JournalCancer
ACS Journal Cancer
3 years
We cannot thank our Editor-in-Chief @DrFadloKhuri enough for everything he has done to make CANCER the journal it is today. Read Dr. Khuri's moving reflection on the past 10 years as he passes the baton to our incoming Editor-in-Chief @RamalingamMD :
Tweet media one
2
10
122
4
9
77
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
3 years
Excited to announce that @AdamMarcusPhD will be the new Deputy Director of @WinshipAtEmory . Feel very fortunate to have a scientist and leader of his caliber on this role. @EmoryMedicine @emoryhealthsci @EmoryUniversity
2
5
77
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
7 years
Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer — NEJM
4
35
70
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
5 years
35% mortality for thoracic cancer patients infected with COVID19; @marinagarassino reports from a global registry @AACR virtual meeting. @IASLC . @WinshipAtEmory
1
35
68
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
4 years
Congrats to @teekayowo ! Bitter sweet to see my long time friend and colleague move to @UPMCHillmanCC , my alma mater. Our shared aspirations will continue to guide continued collaborations. We are proud of you. @WinshipAtEmory @EmoryMedicine
6
4
70
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
6 years
Honored to author this article. @WinshipAtEmory @EmoryMedicine
@NatRevClinOncol
NatureRevClinOncol
6 years
The second of our Year in Review articles is this one by Jennifer Carlisle & Suresh Ramalingam: 'LUNG CANCER IN 2018: A banner year for immunotherapy and targeted therapy'
Tweet media one
0
18
32
0
20
69
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
6 years
Pleasure to welcome @DrewMoghanaki as the newest member of @WinshipAtEmory Thoracic Oncology Team and Radiation Oncology Dept. @WinshipAtEmory @EmoryMedicine .
3
8
67
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
6 years
Congrats to @DrFadloKhuri , recipient of @IASLC Joseph Cullen International Award for Excellence in Cancer Prevention/Early Detection Research! @WinshipAtEmory is proud of this great recognition. @AUB_Lebanon @wallyjc
2
15
68
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
3 years
Congrats to @DrNabilSaba for being named the Lynne and Howard Halpern Chair in Head and Neck Cancer Research at @WinshipAtEmory @EmoryUniversity @EmoryMedicine @ASCO @NRGonc @eaonc . Well deserved recognition for an outstanding scholar.
7
4
67
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
4 years
Results of lung ART trial being presented @myESMO in 2 weeks. Role of RT in resected N2 disease. I can’t wait... #LCSM
@LudaBazhenovaMD
LudaBazhenovaMD
4 years
To my thoracic oncology colleagues. Besides adjuvant chemotherapy and adjuvant osimertinib ( controversy aside), can you think of other breakthroughs in surgically treated disease?
13
4
23
3
10
66
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
5 years
Virtual ⁦ @AACR ⁩ reception after a very successful virtual meeting; >60,000 registrations and fantastic sessions. Congrats to everyone who made this possible. ⁦ @WinshipAtEmory
Tweet media one
1
2
66
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
5 years
This is one of the most exciting studies presented at #ASC019 with direct implications for lung cancer. @IASLC @WinshipAtEmory @AmgenOncology #LCSM
@VamsiVelcheti
Vamsi Velcheti, MD MBA FASCO
5 years
Great early signal w/AMG510 in kRAS G12C... exciting new agent in a difficult to treat/target population. Hope to have an effective targeted therapy option for this population #LCSM #ASCO19
Tweet media one
Tweet media two
Tweet media three
Tweet media four
2
32
80
1
27
66
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
5 years
Thanks to @WinshipAtEmory @wallyjc @EmoryMedicine @emoryhealthcare for the unflinching support. Congrats and thanks to the entire team of the researchers and colleagues that contributed to the Lung SPORE development. We are excited to get started! #LCSM
@WinshipAtEmory
Winship Cancer Institute of Emory University
5 years
Winship Cancer Institute receives a prestigious Lung Cancer SPORE grant from @theNCI that will allow our cancer researchers to develop new approaches for lung cancer patients and improve outcomes. #lungcancer #lcsm
2
16
80
5
3
64
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
5 years
Much awaited survival results from the FLAURA study! ⁦ @WinshipAtEmory #LCSM @AstraZeneca
3
12
64
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
4 years
Congratulations to @n8pennell and @teekayowo on their election to leadership roles in @ASCO ! @WinshipAtEmory @ClevelandClinic #LCSM
3
3
63
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
2 years
Honored to speak at the 2022 Jane Cook Wright MD Symposium at the #NMAATL2022 meeting in Atlanta today along with ⁦ @NCIDirector ⁩ and ⁦ @EdithMitchellMD ⁩. ⁦ @WinshipAtEmory ⁩ ⁦ @theNCI ⁩ ⁦ @EmoryUniversity
Tweet media one
2
5
61
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
2 years
Immensely thankful for the incredible @WinshipAtEmory teams that pulled off a @theNCI CCSG site visit and EPIC go-live the same week! Team work at its best! @emoryhealthcare @EmoryUniversity
Tweet media one
Tweet media two
5
7
63
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
4 years
More good news for the lung cancer field- FDA approves Nivo plus Ipi for 1st line treatment of advanced NSCLC. Another effective option to improve survival . @bmsnews @IASLC @WinshipAtEmory #LCSM
0
10
61
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
4 years
Me: admitting diagnosis: abundance of caution. Insurance company: you must be kidding! @PatelOncology @n8pennell
6
10
61
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
6 years
While an excellent #TTLC19 comes to close, the fight against lung cancer continues... thx to all speakers, participants and @IASLC staff. Thanks @OurSantaMonica @WinshipAtEmory @DrRoyHerbstYale @wallyjc . See you back in 2020.
2
11
58
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
2 years
My sincere thanks to women physicians @WinshipAtEmory , @EmoryMedicine and beyond for their hard work and dedication to improving the lives of our patients on the occasion of National Women Physicians Day.
1
5
58
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
6 months
Great to see lung cancer research highly represented at the @ASCO plenary session. This has been a long time coming! #LCSM @WinshipAtEmory .
@HHorinouchi
Hidehito HORINOUCHI
6 months
⏰NOW OUT‼️ #ASCO24 🔥Plenary Session #LCSM #LBA3 Early palliative care via telehealth vs in person 🎙️Dr.Joseph Greer ✅ #LBA4 LAURA: Osi after CRT in EGFRm 🎙️ @RamalingamMD #LBA5 ADRIATIC: Durva after CRT in ES-SCLC 🎙️ @DavidRSpigel @OncoAlert @ASCO
Tweet media one
0
6
21
2
10
57
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
2 years
@reshmajagsi ⁩ speaking at her welcome reception to ⁦ @EmoryUniversity ⁩ and ⁦ @WinshipAtEmory ⁩. We are excited to have you here.
Tweet media one
1
8
57
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
4 years
No doubt @harpreet_md has had a busy several months reviewing all the applications that resulted in multiple FDA approvals for lung cancer. Thank you from the entire lung cancer community and our patients. @WinshipAtEmory #LCSM @IASLC
@harpreet_md
Harpreet Singh, MD
4 years
Today, FDA approved nivolumab + ipilimumab & 2 cycles of chemotherapy for metastatic NSCLC based on the 9LA study. ✅ Part of OCE’s Project ORBIS ✅ reviewed with HC, TGA, HSA 2️⃣ months ahead of FDA goal . @FDAOncology
5
19
63
3
10
55
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
2 years
Will miss the sights and sounds in Vienna, but certainly not the science, thanks to virtual @IASLC and tweets from @StephenVLiu @HwakeleeMD @LealTiciana @KHigginsMD . #WCLC22 @WinshipAtEmory
3
1
54
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
11 months
Looking forward to the exciting presentations at ⁦ @WinshipAtEmory ⁩ Annual Scientific Symposium today. Keynote lecture by Dr. Carl June. #where science becomes hope. ⁦ @AdamMarcusPhD ⁩ ⁦ @LesinskiLab ⁩ ⁦ @EmoryUniversity
Tweet media one
0
7
56
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
3 years
@AdamMarcusPhD ⁩ honored as a Winship 5K Professor today! A great event to honor an innovative scientist, leader and friend. ⁦ @WinshipAtEmory ⁩ ⁦ @EmoryUniversity ⁩ ⁦ @emoryhealthsci ⁩ ⁦ @wallyjc
Tweet media one
5
4
55
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
2 years
Congrats to ⁦ @WinshipAtEmory ⁩ honorees at ⁦ @ConquerCancerFd ⁩ ceremony at #ASCO22 . ⁦ @MylinTorres ⁩ ⁦ @ASCO ⁩ ⁦ @EmoryUniversity
Tweet media one
0
4
54
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
6 years
After concurrent therapy, this is the first major advance in stage 3 NSCLC. Improved survival firms up the role of Durvalumab in this setting. @WinshipAtEmory #LCSM @AstraZeneca
1
27
55
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
4 years
Congrats to @christine_lovly , on recognition as the ECOG-ACRIN Young Investigator Award @eaonc . This award recognizes her outstanding contributions to thoracic oncology. @VUMC_Cancer @NCICTEP_ClinRes #LCSM @HwakeleeMD
1
1
54
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
5 years
@IASLC ⁩ virtual board meeting this am; great to connect with colleagues from across the world. ⁦ @HwakeleeMD ⁩ ⁦ @giorgioscaglio3 ⁩ ⁦ @DrRoyHerbstYale ⁩ ⁦ @CBelaniMD
Tweet media one
1
3
53
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
6 years
Checkpoint inhibition has 24% RR in BRAF mutated NSCLC- this is the best among various driver mutation groups. #ASCO18 @WinshipAtEmory #LCSM presentation by Dr. Mazieres.
1
23
53
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
5 months
Great to spend a few precious minutes with the ⁦ @NIHDirector ⁩ ⁦ @ASCO ⁩ along with fellow ⁦ @WinshipAtEmory ⁩ faculty member ⁦ @judywawira ⁩. ⁦ @theNCI
Tweet media one
0
8
53
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
4 years
November is Lung Cancer Awareness month! Let us all work together to raise awareness and dispel the nihilism that still exists against lung cancer. ⁦ @jillfeldman4 ⁩ ⁦ @Pattybeatslungc ⁩ ⁦ @WinshipAtEmory
Tweet media one
0
8
53
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
1 year
Congratulations to my good friend and colleague @teekayowo on this appointment! @WinshipAtEmory is proud and sends best wishes. @UMGCCC @AACI_Cancer @eaonc
@UMGCCC
UMGCCC
1 year
We are excited to welcome Dr. Taofeek Owonikoko as our new Executive Director. Dr. Owonikoko, an internationally recognized thoracic oncologist who specializes in treating lung cancer, will take over from Dr. Kevin J. Cullen, who has served as Director for the past 20 years!
Tweet media one
51
29
283
2
5
53
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
5 months
Celebrating #National Clinical Trials Day ⁦ @WinshipAtEmory ⁩. Truly takes a village to conduct clinical trials. >240 individuals including virtual staff living in 25 different states make it possible here! My sincere thanks to all trials teams. ⁦ @theNCI ⁩ ⁦⁦
Tweet media one
1
4
52
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
4 years
Congrats to @bilenma for his appointment as the Director of the Genito-Urinary Medical Oncology Group @WinshipAtEmory ! The program is poised to make great strides under your leadership. @EmoryMedicine @emoryhealthsci
4
3
51
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
1 year
Thanks to ⁦ @HwakeleeMD ⁩ for leading ⁦ @IASLC ⁩ admirably for the past two years. ⁦ @WinshipAtEmory ⁩ ⁦ @Stanford #wclc23
Tweet media one
0
5
51
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
1 year
Thanks to our amazing main lobby staff at the ⁦ @WinshipAtEmory ⁩ Midtown on day 1 of patient care at our new facility. Every patient in my clinic complemented how pleasant their check in experience was. No lines and no waiting! ⁦ @emoryhealthcare
Tweet media one
1
3
49
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
5 years
This exceptional new facility will bring innovative research and outstanding patient care to improve the lives of cancer patients. @WinshipAtEmory @wallyjc @EmoryMedicine @EmoryUniversity
@EmoryUniversity
Emory University
5 years
Emory, @WinshipAtEmory break ground on Midtown Atlanta building designed to put patients at the center of specialized care communities
2
11
52
2
5
49
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
3 years
Thanks for the great support from our patients, families, friends, faculty and staff for @Winship5K @WinshipAtEmory this am. #WhereScienceBecomesHope . @EmoryUniversity @gregfenves @AdamMarcusPhD @emoryhealthcare @EmoryMedicine
0
3
49
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
3 years
@LealTiciana ⁩, the newest addition to ⁦ @WinshipAtEmory ⁩ faculty, discusses role of ct DNA testing in lung cancer. #ALCS2021 . #LCSM
Tweet media one
3
4
48
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
6 years
Honored to serve as co-chair of #TTLC19 with @DrRoyHerbstYale , Paul Bunn and Leora Horn. @WinshipAtEmory @IASLC @giorgioscaglio3
@IASLC
IASLC
6 years
#TTLC19 kicks off in Santa Monica with a packed house for the opening ceremony, including a welcome from IASLC President @giorgioscaglio3
Tweet media one
Tweet media two
0
3
15
0
4
49
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
5 years
With so many @IASLC leaders working on this, I have no doubt that #WCLC19 will be an outstanding success.
@IASLC
IASLC
5 years
The #WCLC19 abstract scheduling session is underway in Barcelona! Nearly 40 of our members have generously donated their weekend to slotting a record number of submitted abstracts into tracks/sessions. We can't thank them enough. It's going to be a great conference! #LCSM
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
12
46
0
8
48
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
4 years
We are getting ready for the ⁦ @Winship5K ⁩ (virtual); just a week away. Join us! ⁦ @WinshipAtEmory ⁩ ⁦ @wallyjc
0
4
48
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
2 years
Thanks @HaianFu for your leadership on getting this exciting team science award from @theNCI . Congrats to the entire team. @AdamMarcusPhD @MBeheraPhD @MMG_PhD @MadhavDhodapkar @WinshipAtEmory . @EmoryUniversity
@WinshipAtEmory
Winship Cancer Institute of Emory University
2 years
Winship has been awarded a P01 program project grant from @TheNCI , nearly $11 million over 5 years, to support research aimed at improving the effectiveness of #immunotherapy for #lungcancer in patients. #lcsm ➡️
Tweet media one
0
7
50
0
6
47
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
6 years
Finally a step forward in SCLC therapy with Atezolizumab plus chemo- HR 0.70 for survival. @IASLC @WinshipAtEmory #WCLC2018 #LCSM
0
18
47
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
6 years
Practice changing presentations at the plenary session of World conf in lung cancer. Congrats to ⁦ @IASLC #WCLC2018 @WinshipAtEmory #LCSM
Tweet media one
0
13
45
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
5 years
Thank you ⁦ @SenatorDurbin ⁩ for fighting to keep our children’s safety and health. ⁦ @IASLC ⁩ . Vaping is a major public health threat to our kids
0
21
47
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
6 years
Pembro plus chemo improved OS with 0.62 HR in squamous NSCLC; effect similar with taxol and nab- pac. @WinshipAtEmory #ASC018 #LCSM . Similar HR across different PDL1 exp groups. Will change SOC.
0
30
46
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
5 years
Excited at be at #ESMO2019 with esteemed colleagues ⁦ @peters_solange ⁩ Dr. Garassino and Dr. Garrido. ⁦ @WinshipAtEmory
Tweet media one
0
5
46
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
3 years
Important work to address disparities in health literacy in our patient population. Congrats to the authors. @WinshipAtEmory
@JournalCancer
ACS Journal Cancer
3 years
New study led by @WinshipAtEmory investigators | Short animated videos, which improved patient understanding of chemotherapy terminology in an underserved urban setting, were also successful in significantly improving understanding in a rural setting.
Tweet media one
2
7
19
2
6
46
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
1 year
Congrats to @AjayNookaMD for his well deserved appointment to this leadership role at @WinshipAtEmory . He brings years of experience, spirit of team work, and excellence in scholarship to this role.
@WinshipAtEmory
Winship Cancer Institute of Emory University
1 year
Winship hematologist Ajay Nooka, MD, MPH, has been named associate director for clinical research, providing strategic oversight for all Winship clinical research with a focus on supporting high-quality, safe and ethical research with equitable access.
13
5
51
1
3
46
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
5 years
Dilemma in clinic:( Insurance denied MRI brain for lung cancer ptient with brain Mets- requests peer to peer. Should I do it now and have clinic patients waiting or risk missing the call by the time my clinic ends ~6 pm? #lcsm
Tweet media one
21
7
46
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
7 years
A new std of care has been defined for adv NSCLC with the results of Keynote 189. Congrats to Dr Leena Gandhi RT al. #AACR2018 #AACR18 @WinshipAtEmory
0
12
43
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
4 years
Indian cricket has seen many champions - none better than captain @msdhoni ! Thanks for the world championships and everlasting memories! @BCCI @VamsiVelcheti @VivekSubbiah @CharuAggarwalMD @DrSanjayPopat @DrRiyazShah @neerajaiims # via @bcci
2
5
45
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
5 years
Big thanks to @eaonc staff for their hard work on EA5508 study; special thanks to @SuzDahlberg @mrzebra1 @HwakeleeMD . Together, we have answered in a definitive manner the question about optimal maintenance therapy for NSCLC @WinshipAtEmory #ASC019 #LCSM . @IASLC
2
7
44
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
3 years
Great discussions to reduce cancer burden in Georgia at the virtual summit today. ⁦ @WinshipAtEmory ⁩ ⁦ @ACS_Georgia ⁩ ⁦ @GeorgiaCORE10 ⁩ ⁦ @theNCI @thecancer
Tweet media one
0
7
43
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
4 years
Thank you ⁦ @emoryhealthcare for the efficient, convenient off-campus location and weekend option to get vaccinated. ⁦ @WinshipAtEmory ⁩ ⁦ @EmoryMedicine
Tweet media one
0
1
44
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
4 years
A past president @ASCO and the president-elect! @hoosierdfh
0
1
44
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
1 year
What a milestone for @JournalCancer ! I am honored to serve as the editor in chief of this amazing journal. @WinshipAtEmory @ACS_Research
@JournalCancer
ACS Journal Cancer
1 year
It's our 75th birthday! 📗 🎉 Since 1948, CANCER has been dedicated to bringing the best of science to the broadest audience—always aligned with the @AmericanCancer mission of ending cancer as we know it, for everyone. 🔗 @RamalingamMD #Cancer75
1
7
21
0
4
43
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
7 years
Fun sprinting up 38 flights of stairs with Team EMORY to raise funds for @LungAssociation . @WinshipAtEmory @wallyjc @EmoryMedicine . 2018 Fight for Air.
Tweet media one
0
3
43
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
5 years
Congrats to @wallyjc for this recognition and honor! His work has changed treatment paradigms for cancer and improved lives of patients the world over. @WinshipAtEmory @EmoryMedicine @emoryhealthcare @ASTRO_org
@WinshipAtEmory
Winship Cancer Institute of Emory University
5 years
At a special ceremony taking place at #ASTRO19 today, Winship Executive Director and Radiation Oncology Chair Walter J. Curran, Jr., MD, will be honored with a 2019 ASTRO Gold Medal for outstanding contributions in the field of radiation oncology. ➡️
Tweet media one
2
8
32
0
10
43
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
2 years
I think the question now shifts to studying chemo plus TKI in ctDNA persistence after 3-6 weeks of TKI therapy. @StephenVLiu
@StephenVLiu
Stephen V Liu, MD
2 years
Are the risks of chemo offset by a PFS gain that does not translate into an OS benefit? How does this frame the results of FLAURA2 (osi +/- chemo), which has a PFS primary endpoint? I would expect RR and PFS to improve - but I think an OS benefit is needed to change the SOC here.
Tweet media one
8
4
33
3
7
42